Anfield Capital Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.85K Sell
507
-27
-5% -$378 ﹤0.01% 481
2025
Q4
$6.65K Buy
534
+27
+5% +$291 ﹤0.01% 374
2025
Q3
$5.02K Hold
507
﹤0.01% 408
2025
Q2
$4.53K Hold
507
﹤0.01% 375
2025
Q1
$4.42K Hold
507
﹤0.01% 339
2024
Q4
$6.31K Hold
507
﹤0.01% 287
2024
Q3
$5.89K Hold
507
﹤0.01% 295
2024
Q2
$5.39K Buy
+507
New +$5.6K ﹤0.01% 255
2021
Q3
Sell
-12
Closed 260
2021
Q2
$0 Buy
+12
New +$174 ﹤0.01% 237

Other funds holding VTRS

Anfield Capital Management's VTRS Position: Q1 2026 in Review

Anfield Capital Management reduced its Viatris (VTRS) stake by 5.1% in Q1 2026, selling an estimated $378 and leaving 507 shares worth $6.85K. The position accounts for ﹤0.01% of the portfolio, ranked #481.

Anfield Capital Management first reported a position in VTRS in Q2 2021 and has held it in 9 quarters since. 1,029 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • Anfield Capital Management held 507 shares of Viatris worth $6.85K as of Q1 2026.
  • Anfield Capital Management sold 27 Viatris shares in Q1 2026, an estimated $378.
  • Viatris made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #481 holding.
  • Anfield Capital Management first reported a position in Viatris in Q2 2021 and has held it in 9 quarters since.
  • 1,029 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.